The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)

ConditionsHIV Prevention Substance Use Mental Health Disorders Sexually Transmitted Infections (STIs)Chemsex

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorInstitute of HIV Research and Innovation Foundation, Thailand

About this trial

This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.

Eligibility criteria

Qualifiers

Self-identified transgender women, transgender men, or non-binary persons

Age ≥18 years

HIV-negative

Engaged in chemsex or substance use within past 12 months

Disqualifiers

None

Trial design

Treatments tested in this trial

Transgender-tailored Harm Reduction Service

Treatment groups

140 Participants

are divided into 1 treatment group

Locations

Tangerine Clinic, Institute of HIV Research and Innovation10330, Pathum WanBangkok, Thailand

Sponsors and collaborators

Institute of HIV Research and Innovation Foundation, Thailand

Lead sponsor

Source ClinicalTrials.gov